Abstract
Man is constructed to eat regular meals. Moreover, man is constructed to prefer food that is energy-rich and tasty. Dietary lipids are both energy-rich and tasty, with several spices being lipid soluble. In the early history of man dietary lipids were scarce but gradually increased with the development of an agricultural society. Since the 1950s dietary fat intake in the Western world has dramatically increased from around 30 energy percent to 40 energy percent (Dreon et al., 1988). This has as a consequence an increased frequency of obesity and insulin resistance, eventually leading to Type 2 diabetes at the moment of failure of the islets of Langerhans (Bray et al., 1990; Steffens et al., 1991; Shafrir and Gutman, 1993). The reason that a high fat intake has serious metabolic implications is that fat taken in is not automatically oxidized in proportion to its consumption as is dietary carbohydrate and protein (Thomas et al., 1992). Instead an increased fat intake leads to the accumulation of fat in skeletal muscle and adipose tissue. The insulin resistance following high-fat feeding is due to an impairment of the insulin receptor signaling events downstream in the target cell, the insulin receptor and its insulin receptor substrates, for instance Insulin receptor substrate 1 (IRS-1) and Phosphatidylinositol-3 kinase (PI3-kinase), being phosphorylated at several serine/threonine residues instead of the normal tyrosine phosphorylation (Paz et al., 1996). In the muscle that is the first tissue to become insulin resistant following high-fat feeding, long-chain acyl-CoA has been shown to raise the levels of protein kinase C, which in turn activates serine/threonine residues (Schmitz Peiffer et al., 1997). In light of the multiple metabolic disturbances of a high dietary fat intake, great interest has been taken in the regulation of appetite, especially with the interest of a specific macronutrient appetite regulation.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Barton, C, Lin L., York D. A., and Bray G. A., 1995, Differential effects of enterostatin, galanin and opioids on high-fat diet consumption, Brain Res. 702:55–60.
Belfrage, P., 1985, Hormonal control of lipid degradation, in: New Perspectives in Adipose Tissue (A. Cryer, and R. L. R. Van, eds), Butterworths, London, pp. 121–144.
Berger, K., Sörhede-Winzell, M., and Erlanson-Albertsson, C., 1998, Binding of enterostatin to the human neuroepithelioma cell line SK-N-MC, Peptides 19:1525–1531.
Blundell, J. E., and Clawton, C. L., 1995, Serotonin and dietary fat intake: Effects of dexfenfluramine, Metabolism 44 (Suppl. 2):33–37.
Borgström, B., Wieloch, T., and Erlanson-Albertsson, C., 1979, Evidence for a pancreatic procolipase and its activation by trypsin, FEBS Lett. 108:407–410.
Bouras, M., Huneau, J. F., Luengo, C., Erlanson-Albertsson, C., and Tomé, D., 1995, Metabolism of enterostatin in rat intestine, brain membranes and serum: Differential involvement of proline-specific peptidases, Peptides 16:399–405.
Bowyer, R. C., Jehanli, A. M. T., Patel, G., and Hermon-Taylor, J., 1991, Development of enzyme-linked immunosorbent assay for free human procolipase activation peptide (APGPR), Clin. Chim. Acta 200:137–152.
Bowyer, R. C., Rowston, W. M., Jehanli, A. M. T., Lacey, J. H., and Hermon-Taylor, J., 1993, The effect of a satiating meal on the concentrations of procolipase activation peptide in the serum and urine of normal and morbidly obese individuals, Gut 34:1520–1525.
Bray, G. A., 1992, Peptides affect the intake of specific nutrients and the sympathetic nervous system, Am. J. Clin. Nutr. 55:2655–2715.
Bray, G. A., Fisler, J. S., and York, D. A., 1990, Neuroendocrine control of the development of obesity: Understanding gained from studies of experimental models of obesity,Prog. Neuroendocrinol. 4:128–181.
Briendley, D. N., 1995, Role of glucocorticoids and fatty acids in the impairement of lipid metabolism observed in the metabolic syndrome, Int. J. Obes. 19 (Suppl. 1): S69–S75.
Cook, C., Gatchair-Rose, A., Herminghuysen, D, Nair, R., Prasad, A., Mizuma, H., and Prasad, C., 1994, Individual differences in the macronutrient profile of outbred rats: implications for nutritional, metabolic and pharmacological studies, Life Sci. 55:1463–1470.
Dreon, D. M., Frey-Hewitt, B., Ellsworth, N., Williams, P. T., Terry, R. B., and Wood, P. D., 1988, Dietary fat: Carbohydrate ratio and obesity in middle aged men, Am. J. Clin. Nutr. 47:995–1000.
Duan, R., and Erlanson-Albertsson, C., 1989, Pancreatic lipase and colipase activity increase in pancreatic acinar tissue of diabetic rats, Pancreas 4:329–334.
Duan, R., and Erlanson-Albertsson, C., 1990, The anticooordinate changes of pancreatic lipase and colipase activity to amylase activity by adrenalectomy in normal and diabetic rats,Int. J. Pancreatol. 6:271–279.
Duan, R., and Erlanson-Albertsson, C., 1992, Gastric inhibitory polypeptide stimulates pancreatic lipase and colipase synthesis in rats, Amer. J. Physiol. 262 :G779–G784.
Duan, R., Wicker, C., and Erlanson-Albertsson, C., 1991, Effect of insulin administration on contents, secretion and synthesis of pancreatic lipase and colipase in rats, Pancreas 6:595–602.
Erlanson-Albertsson, C., 1992, Pancreatic colipase. Structural and physiological aspects. Biochim. Biophys. Acta 1125:1–7.
Erlanson-Albertsson, C., 1994, Pancreatic lipase, colipase and enterostatin-A lipolytic triad, in: Esterases, Lipases and Phospholipases: From Structure to Clinical Significance (M. I. Mackness and M. Clerc, eds.), Plenum Press, New York, pp. 159–168.
Erlanson-Albertsson, C., and Larsson, A., 1988, A possible physiological function of procolipase activation peptide in appetite regulation, Biochimie 70:1245–1250.
Erlanson-Albertsson, C., and York, D. A., 1997, Enterostatin-Apeptide regulating fat intake, Obes. Res. 5:360–372.
Erlanson-Albertsson, C., Mei, J., Okada, S., York, D., and Bray, G. A., 1991a, Pancreatic procolipase propeptide, enterostatin, specifically inhibits fat intake, Physiol. Behav. 49:1191–1194.
Erlanson-Albertsson, C., Weström, B., Pierzynowski, S., Karlsson, S., and Ahrén B., 1991b, Pancreatic procolipase activation peptide-enterostatin-inhibits pancreatic enzyme secretion in the pig, Pancreas 6:619–624.
Erlanson-Albertsson, C., Hering, B. J., Bretzler, B. G., and Federlin, K., 1994, Enterostatin inhibits insulin secretion from isolated perifused rat islets, Acta Diabetol. 31:160–164.
Fisler, J. S., and Bray, G. A., 1995, Dietary obesity: Effects of drugs on food intake in S5B/PL and Osborne-Mendel rats, Physiol. Behav. 34:225–231.
Gabert, V. M., Jensen, M. S., Jörgensen, H:, Engberg, R. M., and Jensen, S. K., 1996, Exocrine pancreatic secretion in growing pigs fed diets containing fish oil, rapeseed oil or coconut oil, J. Nutr. 126:2076–2082.
Hermoso, J., Pignol, D., Penel, S., Roth, M., Chapus, C., and Fontecilla-Camps, J. C., 1997, Neutron crystallographic evidence of lipase-colipase complex activation by a micelle, EMBO J. 16:5531–5536.
Huneau, J. F., Erlanson-Albertsson, C., Beauvallet, C., and Tomé, D., 1994, The in vitro absorption of enterostatin is limited by brush border membrane peptidases, Regul. Pept. 54:495–503.
Kiela, P., Pierzynowski, S. G., Oldak, T., Ceregrzyn, M., Erlanson-Albertsson, C., Wiechetek, M., and Garwacki, S., 1994, The effect of enterostatin on pig duodenal, jejunal and ileal motility in vitro, Biomed. Res. 15 (Suppl. 2):303–307.
Leibowitz, S. F., 1994, Specificity of hypothalamic peptides in the control of behavioural and physiological processes, Ann. N. Y Acad. Sci. 739:12–35.
Levine, A. S., Morley, J. E., Gosnell, B. A., Billington, C. J., and Bartness, T. J., 1985, Opioids and consummatory behaviour, Brain Res. Bull. 14:663–672.
Lin, L., and York, D. A., 1997, Comparisons of the effects of enterostatin on food intake and gastric emptying in rats, Brain Res. 745:205–209.
Lin, L., Gehlert, D. R., York, D. A., and Bray, G. A., 1993a, Effect of enterostatin on the feeding responses to galanin and NPY, Obes. Res.1:186–192.
Lin, L., McClanahan, S., York, D. A., and Bray, G. A., 1993b, The peptide enterostatin may produce early satiety, Physiol. Behav. 53:789–794.
Lin, L., Chen, J., and York, D. A., 1997, Chronic ICV enterostatin preferentially reduced fat intake and lowered body weight,Peptides 18:651–655.
Mei, J., and Erlanson-Albertsson, C., 1992, Effect of enterostatin given intravenously and intracerebroventricularly on high-fat feeding in rats, Regul. Pept. 41:209–218.
Mei, J., and Erlanson-Albertsson, C., 1996a, Plasma insulin response to enterostatin and effect of adrenalectomy in rat, Obes. Res. 4:513–519.
Mei, J., and Erlanson-Albertsson, C., 1996b, Role of intraduodenally administered enterostatin in rat: Inhibition of food intake, Obes. Res.4:161–165.
Mei, J., Cheng, Y., and Erlanson-Albertsson, C., 1993a, Enterostatin-Its ability to inhibit insulin secretion and to decrease high-fat food intake, Int. J. Obes. 17:701–704.
Mei, J., Bowyer, R. C., Jehanli, A.M.T., Patel, G., and Erlanson-Albertsson, C., 1993b, Identification of enterostatin, the pancreatic procolipase activation peptide, in the intestine of rat: Effect of CCK-8 and high-fat feeding, Pancreas 8:488–493.
Mei, J., Bouras, M., and Erlanson-Albertsson, C., 1997, Inhibition of insulin release by intraduodenally infused enterostatin-VPDPR in rats, Peptides 18:651–655.
Mizuma, H., Abadie, J., and Prasad, C., 1994, Corticosterone facilitation of inhibition of fat intake by enterostatin (Val-Pro-Asp-Pro-Arg), Peptides 15:447–452.
Nagase, H., Bray, G. A., and York, D. A., 1997, Effect of galanin and enterostatin on sympathetic nerve activity to intrascapular brown adipose tissue, Brain Res. 709:44–50.
Okada, S., York, D. A., Bray, G. A., and Erlanson-Albertsson, C., 1991, Enterostatin (Val-Pro-Asp-Pro-Arg) the activation peptide of procolipase selectively reduces fat intake, Physiol. Behav.49:1185–1189.
Okada, S., York, D. A., Bray, G. A., Mei, J., and Erlanson-Albertsson, C., 1992, Differential inhibition of fat intake in two strains of rat by the peptide enterostatin, Amer. J. Physiol. 262:R1111–R1116.
Okada, S., Onai, T., Kilroy, G., York, D. A., and Bray, G. A., 1993a, Adrenalectomy of the obese Zucker rat: Effects on the feeding response to enterostatin and specific mRNA levels,Amer. J. Physiol. 265:R21–R27.
Okada, S., Lin, L., York, D. A., and Bray, G. A., 1993b, Chronic effects of intracerebral ventricular enterostatin in Osborne-Mendel rats fed a high-fat diet, Physiol. Behav. 54:325–330.
Okada, S., York, D. A., and Bray, G. A., 1993c, Procolipase mRNA: Tissue localization and effects of diet and adrenalectomy, Biochem. J. 292:787–789.
Ookuma, K., Barton, C., York, D. A., and Bray, G. A., 1997, Effect of enterostatin and kappa-opioids on macronutrient selection and consumption, Peptides 18:785–791.
Pan, D. H., Hulbert, A. J., and Storlien, L. H., 1994, Dietary fats, membrane phospholipids and obesity,J. Nutr. 124:1555–1565.
Paz, K., Voliovitch, H., Hadari, Y. R., Roberts, C. T., LeRoith, D., and Zick, Y., 1996, Interaction beween the insulin receptor and its downstream effectors. Use of individually expressed receptor domains for structure/function analysis, J. Biol. Chem. 271:6998–7003.
Pierzynowski, S. G., Erlanson-Albertsson, C., Podgurniak, P., Kiela, P., and Weström B., 1994, Possible integration of the electrical activity of the duodenum and pancreas secretion through enterostatin, Biomed. Res. 15(Suppl. 2):257–260.
Rippe, C., and Erlanson-Albertsson, C., 1998, Identification of enterostatin and the relationship between lipase and colipase in various species, Nutritional Neuroscience 1:111–117.
Schmitz Peiffer, C., Browne, C. L., Oakes, N. D., Watkinson, A., Chisholm, D. J., Kraegen, E. W., and Biden, T. J., 1997, Alterations in the expression and cellular localization of protein kinase C isozymes ε and ϕ are assocoated with insulin resistance in skeletal muscle of the high-fat fed rat, Diabetes 46:169–178.
Shafrir, E., and Gutman, A., 1993, Psammomys obesus of the Jerusalem colony: Amodel for nutritionally induced, non-insulin dependent diabetes, J. Basic Clin. Physiol. Pharmacol.4:83–99.
Shargill, N. S., Tsujii, S., Bray, G. A., and Erlanson-Albertsson, C., 1991, Enterostatin suppresses food intake following injection into the third ventricle of rats, Brain Res. 544:137–140.
Shor-Posner, G., Brennan, G., Ian, C., Jasaitis, R., Madhu, K., and Leibowitz, S. F., 1994, Meal patterns of macronutrient intake in rats with particular dietary preferences, Am. J. Physiol. 266:R1395–R1402.
Silvestre, R. A., Rodrigeux-Gallardo, J., and Marco, J., 1996, Effect of enterostatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas, Diabetes 45:1157–1160.
Smith, B. K., York, D. A., and Bray, G. A., 1997, Chronic d-fenfluramine treatment reduces fat intake and increases carbohydrate intake in rats, Pharmacol. Biochem. Behav. 18:207–211.
Sörhede, M., Mei, J., and Erlanson-Albertsson, C., 1993, Enterostatin-a gut-brain peptide-regulating fat intake in rat, J. Physiol. (Paris) 87:273–275.
Sörhede, M., Erlanson-Albertsson, C., Mei, J., Nevalainen, T., Aho, A., and Sundler, F., 1996a, Enterostatin in gut endocrine cells-Immunocytochemical evidence, Peptides 17:609–614.
Sörhede, M., Mulder, H., Mei, J., Sundler, F., and Erlanson-Albertsson, C., 1996b, Procolipase is produced in the rat stomach-a novel source of enterostatin. Biochim Biophys Acta. 1301:207–212.
Sörhede-Winzell, M., 1998, Enterostatin in the gastrointestinal tract: Production and possible mechanism of action. Ph.D. diss., University of Lund.
Stanley, B. G., Daniel, D. R., Chin, A. S., and Leibowitz, S. F., 1985, Paraventricular nucleus injection of peptide YY and neuropeptide Y preferentially enhance carbohydrate ingestion, Peptides 6:1205–1211.
Steffens, A. B., Strubbe, J. H., Balkan, B., and Scheurink, A. J., 1991, Neuroendocrine factors regulating blood glucose, plasma FFA and insulin in the development of obesity, Brain Res. Bull. 27:505–510.
Tempel, D. L., Leibowitz, K. J., and Leibowitz, S. F., 1988, Effects of PVN galanin on macronutrient selection, Peptides 9:309–314.
Thomas, C. D., Peters, J. C., Reed, G. W., Abumrad, N. N., Sun, M., and Hill, J. O., 1992, Nutrient balance and energy expenditure during ad libitum feeding of high-fat and high-carbohydrate diets in humans, Am. J. Clin. Nutr. 55:934–942.
Tian, Q., Nagase, H., York, D. A., and Bray, G. A., 1994, Vagal-central nervous system interactions modulate the feeding response to peripheral enterostatin, Obes. Res. 2:527–534.
Townsley, M. I., Erlanson-Albertsson, C., Ohlsson, A., Rippe, C., and Reed, R. K., 1996, Enterostatin efflux in cat intestinal lymph: Relation to lymph flow, hyaluronan and fat absorption, Am. J. Physiol. 271:G714–G721.
Van Amelsvoort, J. M., Van Stratum, R, Kraal, J. H., Lussenberg, R. N., and Houtsmuller, V. M. T., 1988, Effects of varying the carbohydrate: fat ratio in a hot lunch on postprandial variables in male volunteers, Br. J Nutr. 61:267–283.
Vanderweele, D. A., and Macrum, B. L., 1986, Glucagon, satiety from feeding and liver pancreatic interactions, Brain Res. Bull. 17:539–543.
Wicker, C., and Puigserver, A., 1987, Effects of inverse changes in dietary lipid and carbohydrate on the synthesis of some pancreatic secretory proteins, Eur. J. Biochem. 162:25–30.
Wurtman, J., Wurtman, R., Berry, E., Gleason, R., Goldberg, H., McDermott, J., Kahne, M., and Tsay, R., 1993, Dexfenfluramine, fluoxetine, and weight loss among female carbohydrate cravers, Neuropsychopharmacol. 9:201–210.
York, D. A., 1992, Central regulation of appetite and autonomic activity by CRH, glucocorticoids and stress, Prog. Neuroendoc. Immunol.5:153–165.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Erlanson-Albertsson, C. (2001). Enterostatin/Procolipase. In: Mansbach, C.M., Tso, P., Kuksis, A. (eds) Intestinal Lipid Metabolism. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1195-3_6
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1195-3_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5435-2
Online ISBN: 978-1-4615-1195-3
eBook Packages: Springer Book Archive